We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Board Rejects Challenge Of Blood Clotting Protein Patent In Final Decision

Mealey's (April 8, 2018, 10:35 PM EDT) -- ALEXANDRIA, Va. — Allegations that a claimed method for improving the viral safety of liquid compositions comprising “Factor VII” (FVII) — a protein involved in the blood clotting process — is...
To view the full article, register now.